Home : FDA Drug Database : Amrix : MSN Newsfeeds
Amrix - MSN Newsfeeds
- MSNBC - Allegiant Multi-Factor Small Cap Value I (AMRIX), an institutional fund that hasn't had a winning season since 2004 and is losing to the S&P again in 2007. Forward Hoover Small Cap Equity (FFSCX), a no-load fund that flips its portfolio at least twice ...
- MONTVALE, N.J., Nov. 26 /PRNewswire/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Anesta in connection with its Amrix(R) (cyclobenzaprine ...
- ... today confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc. and Anesta AG in connection with the filing of an Abbreviated New Drug Application (ANDA) for Cyclobenzaprine Hydrochloride ...
- Sales of Amrix, the once-daily skeletal muscle relaxant by Cephalon, were $73.6 million in its first full year on the market. Cephalon continues to provide strong support for Amrix and recently realigned an expanded it’s sales force by nearly 50%.
- The increase was due primarily to sales of PANCRELIPASE, to higher royalties, in particular from AMRIX by Cephalon, and to higher development fees. Product sales grew 19% or 9% at constant currency rates to EUR 24.1 million ($33.8 million) in the ...
- Nuvigil, Treanda and Amrix will drive the company's growth this year, Baldino told investors and Wall Street analysts in a conference call Tuesday. The company also updated its guidance for 2009. It remains $2.175 to $2.225 billion. For the third ...
- Patent Application Covering Amrix - Quick Facts [EURX] 4/9/2008 5:53:23 PM Eurand N.V. (EURX) announced that the United States Patent and Trademark Office has issued a notice of allowance for U.S. patent application entitled "Modified Release Dosage ...






